Wrong. Wrong and wrong. You couldn't be more wrong. Aezs stock is still a huge bargain at the current price. We could see $6-$7 on European approval of Macrilen as early as this week. Then i think Aezs immediately after European approval will either enter into a big licensing deal for Macrilen and the share price will go to $12-$15 or alternatively AEZS will get bought out by Novo Nordisk or other big pharma for $18-20 per share. These are just my opinions. Do your own research and due diligence.
News 
Market Data 
Discover 
